[Valdoxan (agomelatine) in combined therapy of moderate and severe non-psychotic depressions].

According to data received from the study VREMYA, the combined therapy of moderate and severe non-psychotic depressions with Valdoxane and antidepressants of other pharmacological groups is effective and doesn't cause serious adverse events. These findings suggested using the indicated combination of antidepressants in treatment of resistant affective disorders.